- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: fixed dose combination tablets
Total 38816 results
-
ANRS, Emerging Infectious DiseasesNot yet recruiting
-
International Bio serviceNot yet recruiting
-
ANRS, Emerging Infectious DiseasesGilead Sciences; Ministry of Health, Thailand; Assistance Publique - Hôpitaux... and other collaboratorsNot yet recruiting
-
PfizerCompletedHealthy Participants | Biological AvailabilityUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Arthralgia | Infection, Human Immunodeficiency VirusSpain, Russian Federation
-
Laboratorios Silanes S.A. de C.V.Completed
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
GL Pharm Tech CorporationCompletedHealthyKorea, Republic of
-
ViiV HealthcareJanssen, LPCompleted
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
TakedaCompleted
-
Grünenthal GmbHGrünenthal, S.A.Withdrawn
-
GL Pharm Tech CorporationCompletedHealthyKorea, Republic of
-
GlaxoSmithKlineHammersmith Medicines Research; Covance HarrogateCompletedHypertension, PulmonaryUnited Kingdom
-
Daiichi Sankyo, Inc.Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyCompletedEssential HypertensionBelgium, Germany, Netherlands, Slovakia
-
Daiichi Sankyo, Inc.Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyCompletedEssential HypertensionFrance, Poland, Ukraine, Germany, Spain, Bulgaria, Czechia
-
Ardea Biosciences, Inc.Completed
-
Boehringer IngelheimCompleted
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompletedHealthy Subjects in Fasted and Fed StateBrazil
-
AstraZenecaCompletedBioequivalence | Fixed Dose Combination Tablets | Healthy Male and Female SubjectsUnited States
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Hoffmann-La RocheCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
Eisai Co., Ltd.Completed
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil
-
Boehringer IngelheimCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimCompleted